Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A V Bono

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
International Surgery|July 1, 1996
Hemostatic efficacy and safety of TachoComb in surgery. Ready to use and rapid hemostatic agentG B Agus, A V Bono, E Mira, et al.
Anticancer Research|August 17, 2005
Differential diagnosis and evaluation of the clinical course of transurethrally resected T1G3 urothelial carcinoma of the bladder by DNA image cytometryS Biesterfeld, H Borchers, H Jellouschek, et al.
International Journal of Clinical Practice|May 2, 2003
Management of locally advanced prostate cancer: a European consensusL Boccon-Gibod, A Bertaccini, A V Bono, et al.
European Journal of Cancer & Clinical Oncology|January 1, 1982
An EORTC phase II study of methyl-glyoxal bis-guanylhydrazone in advanced renal cell cancerJ A Child, A V Bono, S D Fossa, et al.
Pathology, Research and Practice|May 25, 1999
Effect of total androgen ablation on pathologic stage and resection limit status of prostate cancer. Initial results of the Italian PROSIT studyR Montironi, L Diamanti, A Santinelli, et al.
Urologia Internationalis|May 1, 1998
Complete androgen blockade versus chemical castration in advanced prostatic cancer: analysis of an Italian multicentre study. Italian Leuprorelin GroupA V Bono, F DiSilverio, G Robustelli della Cuna, et al.
International Journal of Immunopathology and Pharmacology|July 22, 2010
Immunohistochemical expression and localization of somatostatin receptor subtypes in prostate cancer with neuroendocrine differentiationD Morichetti, R Mazzucchelli, A Santinelli, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1984
Mitoxantrone in advanced renal cancer: a phase II study in previously untreated patients from the EORTC Genito-Urinary Tract Cancer Cooperative GroupA T van Oosterom, S D Fosså, G Pizzocaro, et al.
La Medicina Del Lavoro|April 3, 2010
[Validation of a screening method for occupational bladder cancer]Rossana Borchini, M Bonzini, G Veronesi, et al.
Cancer Genetics and Cytogenetics|August 1, 1995
Clonal chromosome changes in non-neoplastic uretersR Casalone, E Minelli, R Righi, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
International Surgery|July 1, 1996
Hemostatic efficacy and safety of TachoComb in surgery. Ready to use and rapid hemostatic agentG B Agus, A V Bono, E Mira, et al.
Anticancer Research|August 17, 2005
Differential diagnosis and evaluation of the clinical course of transurethrally resected T1G3 urothelial carcinoma of the bladder by DNA image cytometryS Biesterfeld, H Borchers, H Jellouschek, et al.
International Journal of Clinical Practice|May 2, 2003
Management of locally advanced prostate cancer: a European consensusL Boccon-Gibod, A Bertaccini, A V Bono, et al.
European Journal of Cancer & Clinical Oncology|January 1, 1982
An EORTC phase II study of methyl-glyoxal bis-guanylhydrazone in advanced renal cell cancerJ A Child, A V Bono, S D Fossa, et al.
Pathology, Research and Practice|May 25, 1999
Effect of total androgen ablation on pathologic stage and resection limit status of prostate cancer. Initial results of the Italian PROSIT studyR Montironi, L Diamanti, A Santinelli, et al.
Urologia Internationalis|May 1, 1998
Complete androgen blockade versus chemical castration in advanced prostatic cancer: analysis of an Italian multicentre study. Italian Leuprorelin GroupA V Bono, F DiSilverio, G Robustelli della Cuna, et al.
International Journal of Immunopathology and Pharmacology|July 22, 2010
Immunohistochemical expression and localization of somatostatin receptor subtypes in prostate cancer with neuroendocrine differentiationD Morichetti, R Mazzucchelli, A Santinelli, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1984
Mitoxantrone in advanced renal cancer: a phase II study in previously untreated patients from the EORTC Genito-Urinary Tract Cancer Cooperative GroupA T van Oosterom, S D Fosså, G Pizzocaro, et al.
La Medicina Del Lavoro|April 3, 2010
[Validation of a screening method for occupational bladder cancer]Rossana Borchini, M Bonzini, G Veronesi, et al.
Cancer Genetics and Cytogenetics|August 1, 1995
Clonal chromosome changes in non-neoplastic uretersR Casalone, E Minelli, R Righi, et al.
Pageof 4